Bath & Body Works (NYSE:BBWI) Director Acquires $300,800.00 in Stock

Bath & Body Works, Inc. (NYSE:BBWI) Director Steven Voskuil bought 20,000 shares of Bath & Body Works stock in a transaction dated Friday, November 21st. The shares were bought at an average cost of $15.04 per share, with a total value of $300,800.00. Following the completion of the acquisition, the director owned 33,925 shares of the company’s stock, valued at $510,232. The trade was a 143.63% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Bath & Body Works Trading Up 2.9%

NYSE BBWI opened at $17.40 on Thursday. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $41.87. The company has a market cap of $3.59 billion, a PE ratio of 5.16, a PEG ratio of 0.86 and a beta of 1.53. The stock’s 50-day moving average price is $24.02 and its two-hundred day moving average price is $27.83.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Thursday, November 20th. The company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the business earned $0.49 earnings per share. The business’s quarterly revenue was down 1.0% compared to the same quarter last year. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. Research analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 4.6%. The ex-dividend date of this dividend is Friday, November 21st. Bath & Body Works’s payout ratio is 24.62%.

Analyst Upgrades and Downgrades

BBWI has been the subject of several recent analyst reports. Telsey Advisory Group cut Bath & Body Works from an “outperform” rating to a “market perform” rating and decreased their target price for the stock from $38.00 to $17.00 in a research report on Friday, November 21st. Morgan Stanley restated an “equal weight” rating and set a $18.00 price objective (down from $43.00) on shares of Bath & Body Works in a research report on Friday, November 21st. Weiss Ratings reiterated a “hold (c-)” rating on shares of Bath & Body Works in a report on Wednesday, October 8th. The Goldman Sachs Group lowered shares of Bath & Body Works from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $39.00 to $17.00 in a research report on Thursday, November 20th. Finally, New Street Research set a $26.00 price objective on shares of Bath & Body Works in a research report on Monday. Six investment analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Bath & Body Works currently has an average rating of “Hold” and a consensus target price of $25.17.

Institutional Investors Weigh In On Bath & Body Works

Several large investors have recently made changes to their positions in the company. T. Rowe Price Investment Management Inc. raised its position in Bath & Body Works by 7.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock valued at $334,029,000 after acquiring an additional 781,681 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Bath & Body Works by 11.5% during the 2nd quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company’s stock worth $212,120,000 after purchasing an additional 733,000 shares during the last quarter. Alliancebernstein L.P. raised its holdings in shares of Bath & Body Works by 2.2% during the 3rd quarter. Alliancebernstein L.P. now owns 5,861,444 shares of the company’s stock valued at $150,991,000 after purchasing an additional 123,648 shares in the last quarter. Cooper Creek Partners Management LLC raised its holdings in shares of Bath & Body Works by 42.7% during the 2nd quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company’s stock valued at $162,081,000 after purchasing an additional 1,619,276 shares in the last quarter. Finally, American Century Companies Inc. lifted its stake in shares of Bath & Body Works by 2,204.1% in the 3rd quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock valued at $133,292,000 after purchasing an additional 4,949,796 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.